Humanized antibody molecules to cd138 and uses thereof
US-2025382379-A1 · Dec 18, 2025 · US
This page is not indexed by search engines while we improve data quality.
Shriver Zachary patents
Shriver Zachary is listed as an inventor on 75 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Shriver Zachary |
| Total patents | 75 |
| First publication | Jan 6, 2015 |
| Latest publication | Dec 18, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Antibody molecules to C5AR1 and uses thereof
US-12415865-B2 · Sep 16, 2025 · US
Humanized antibody molecules to CD138 and uses thereof
US-12338291-B2 · Jun 24, 2025 · US
Humanized complement 5a receptor 1 antibodies and methods of use thereof
US-2025171555-A1 · May 29, 2025 · US
Interleukin-2 agents and uses thereof
US-12297249-B2 · May 13, 2025 · US
Humanized complement 5a receptor 1 antibodies and methods of use thereof
US-12264203-B2 · Apr 1, 2025 · US
Interleukin-2 agents and uses thereof
US-2025059249-A1 · Feb 20, 2025 · US
Humanized complement 5A receptor 1 antibodies and methods of use thereof
US-12227587-B2 · Feb 18, 2025 · US
Antibody molecules to april and uses thereof
US-2025043014-A1 · Feb 6, 2025 · US
Antibody molecules to C5AR1 and uses thereof
US-12187807-B2 · Jan 7, 2025 · US
Recent patents
Latest publications not already listed above.
Humanized complement 5a receptor 1 antibodies and methods of use thereof
US-2025002603-A1 · Jan 2, 2025 · US
Antibody molecules to dengue virus and uses thereof
US-2024425569-A1 · Dec 26, 2024 · US
Humanized complement 5a receptor 1 antibodies and methods of use thereof
US-2024392029-A1 · Nov 28, 2024 · US
Methods of using interleukin-2 agents
US-2024376173-A1 · Nov 14, 2024 · US
Methods of using interleukin-2 agents
US-12098178-B2 · Sep 24, 2024 · US
Antibody molecules to cd138 and uses thereof
US-2024301065-A1 · Sep 12, 2024 · US
Interleukin-2 agents and uses thereof
US-12084484-B2 · Sep 10, 2024 · US
Antibody molecules to dengue virus and uses thereof
US-12054539-B2 · Aug 6, 2024 · US
Interleukin-2 agents and uses thereof
US-2024247040-A1 · Jul 25, 2024 · US
Ha binding agents
US-12024552-B2 · Jul 2, 2024 · US
Antibody Molecules to C5AR1 and Uses Thereof
US-2024150488-A1 · May 9, 2024 · US
Binding polypeptides and methods of making the same
US-2024141334-A1 · May 2, 2024 · US
Antibody molecules to CD138 and uses thereof
US-11945868-B2 · Apr 2, 2024 · US
Antibody molecules to april and uses thereof
US-2024092921-A1 · Mar 21, 2024 · US
Antibody Molecules to C5AR1 and Uses Thereof
US-2024076398-A1 · Mar 7, 2024 · US
Humanized complement 5A receptor 1 antibodies and methods of use thereof
US-11912781-B2 · Feb 27, 2024 · US
Antibody molecule-drug conjugates and uses thereof
US-11890319-B2 · Feb 6, 2024 · US
IMMUNOSILENCING Fc VARIANTS
US-2023416372-A1 · Dec 28, 2023 · US
Binding polypeptides and methods of making the same
US-11820979-B2 · Nov 21, 2023 · US
Antibody molecules to C5aR1 and uses thereof
US-11773179-B2 · Oct 3, 2023 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Visterra Inc | 62 |
| Momenta Pharmaceuticals Inc | 11 |
| Massachusetts Gen Hospital | 3 |
| Bosques Carlos J | 1 |
| Murphy Jennifer Lynn | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K2039/505 | 54 |
| C07K2317/92 | 44 |
| C07K2317/76 | 40 |
| C07K2317/565 | 35 |
| C07K2317/33 | 34 |